XML 95 R81.htm IDEA: XBRL DOCUMENT v3.20.4
Business Combinations - Assets and Liabilities (Details) - USD ($)
$ in Thousands
Jun. 19, 2020
Dec. 31, 2020
Dec. 31, 2019
Business Combination Segment Allocation [Line Items]      
Goodwill   $ 58,632 $ 15,714
Progenics      
Business Combination Segment Allocation [Line Items]      
Cash and cash equivalents $ 15,421    
Accounts receivable 5,787    
Inventory 1,075    
Other current assets 3,684    
Property, plant and equipment 14,972    
IPR&D 151,100    
Other long-term assets 37,631    
Accounts payable (1,616)    
Accrued expenses and other liabilities (8,287)    
Other long-term liabilities (31,158)    
Long-term debt and other borrowings (40,200)    
Deferred tax liabilities (3,418)    
Goodwill 42,918    
Total consideration transferred 419,009    
Progenics | Previously Reported      
Business Combination Segment Allocation [Line Items]      
Cash and cash equivalents 15,421    
Accounts receivable 5,787    
Inventory 915    
Other current assets 3,250    
Property, plant and equipment 14,972    
IPR&D 150,900    
Other long-term assets 37,631    
Accounts payable (1,616)    
Accrued expenses and other liabilities (8,207)    
Other long-term liabilities (30,778)    
Long-term debt and other borrowings (40,200)    
Deferred tax liabilities (3,717)    
Goodwill 42,051    
Total consideration transferred 419,009    
Progenics | Revision of Prior Period, Adjustment      
Business Combination Segment Allocation [Line Items]      
Cash and cash equivalents 0    
Accounts receivable 0    
Inventory 160    
Other current assets 434    
Property, plant and equipment 0    
IPR&D 200    
Other long-term assets 0    
Accounts payable 0    
Accrued expenses and other liabilities (80)    
Other long-term liabilities (380)    
Long-term debt and other borrowings 0    
Deferred tax liabilities 299    
Goodwill 867    
Total consideration transferred $ 0    
Progenics | Currently marketed product      
Business Combination Segment Allocation [Line Items]      
Finite-Lived Intangible Asset, Useful Life 15 years    
Identifiable intangible assets $ 142,900    
Progenics | Currently marketed product | Previously Reported      
Business Combination Segment Allocation [Line Items]      
Identifiable intangible assets 142,100    
Progenics | Currently marketed product | Revision of Prior Period, Adjustment      
Business Combination Segment Allocation [Line Items]      
Identifiable intangible assets $ 800    
Progenics | Licenses      
Business Combination Segment Allocation [Line Items]      
Finite-Lived Intangible Asset, Useful Life 11 years 6 months    
Identifiable intangible assets $ 85,800    
Progenics | Licenses | Previously Reported      
Business Combination Segment Allocation [Line Items]      
Identifiable intangible assets 87,500    
Progenics | Licenses | Revision of Prior Period, Adjustment      
Business Combination Segment Allocation [Line Items]      
Identifiable intangible assets $ (1,700)    
Progenics | Developed technology      
Business Combination Segment Allocation [Line Items]      
Finite-Lived Intangible Asset, Useful Life 9 years    
Identifiable intangible assets $ 2,400    
Progenics | Developed technology | Previously Reported      
Business Combination Segment Allocation [Line Items]      
Identifiable intangible assets 3,000    
Progenics | Developed technology | Revision of Prior Period, Adjustment      
Business Combination Segment Allocation [Line Items]      
Identifiable intangible assets $ (600)